Tower Research Capital LLC (Trc) Rani Therapeutics Holdings, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,721 shares of RANI stock, worth $2,512. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,721

Previous 14,437 88.08%

Holding current value

$2,512

Previous $54,000 94.44%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.06 - $3.99 $26,194 - $50,736	-12,716 Reduced 88.08%	1,721 $3,000
Q2 2024 Aug 13, 2024	BUY	$3.13 - $7.85 $41,309 - $103,604	13,198 Added 1065.21%	14,437 $54,000
Q1 2024 May 15, 2024	SELL	$2.98 - $3.8 $3,185 - $4,062	-1,069 Reduced 46.32%	1,239 $3,000
Q4 2023 Feb 13, 2024	BUY	$1.85 - $3.67 $4,269 - $8,470	2,308 New	2,308 $7,000
Q2 2023 Aug 14, 2023	BUY	$3.92 - $5.58 $12,587 - $17,917	3,211 Added 83.69%	7,048 $29,000
Q1 2023 May 09, 2023	BUY	$5.07 - $6.89 $6,743 - $9,163	1,330 Added 53.05%	3,837 $20,000
Q4 2022 Feb 10, 2023	BUY	$5.51 - $10.02 $6,220 - $11,312	1,129 Added 81.93%	2,507 $15,000
Q3 2022 Nov 10, 2022	SELL	$8.23 - $12.4 $1,687 - $2,542	-205 Reduced 12.95%	1,378 $13,000
Q2 2022 Aug 15, 2022	BUY	$8.0 - $14.25 $8,360 - $14,891	1,045 Added 194.24%	1,583 $16,000
Q1 2022 May 12, 2022	SELL	$12.21 - $23.14 $25,738 - $48,779	-2,108 Reduced 79.67%	538 $7,000
Q4 2021 Feb 14, 2022	BUY	$16.09 - $35.0 $42,574 - $92,610	2,646 New	2,646 $43,000

Others Institutions Holding RANI

# of Institutions

Shares Held

5.77M

Call Options Held

2.5K

Put Options Held

2.2K

View Full List

About Rani Therapeutics Holdings, Inc.

Ticker RANI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,492,000
Market Cap $35.8M
Description
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...

More about RANI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Rani Therapeutics Holdings, Inc. Transaction History